Vanda Pharmaceuticals hits another snag with FDA

Washington Business Journal

Mar 19, 2020

Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) is facing yet another roadblock from regulators. The D.C. company said in a federal filing it received a March 12 letter from the Food and…